Evidence map›Paper›PMID 30936335›Full record

ArticleBMJ case reports2019

Supportive mistletoe therapy in a patient with metastasised neuroblastoma.

Jens Kaestner, Dietrich Schlodder, Christfried Preussler, Bernd Gruhn

Open access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jens KaestnerKlinik für Kinder- und Jugendmedizin, Friedrich-Schiller-Universität Jena, Jena, Germany.
Dietrich SchlodderResearch and Development, Helixor Heilmittel GmbH, Rosenfeld, Germany.
Christfried PreusslerMedical Science, Helixor Heilmittel GmbH, Rosenfeld, Germany.
Bernd GruhnKlinik für Kinder- und Jugendmedizin, Friedrich-Schiller-Universität Jena, Jena, Germany.
Friedrich Schiller University Jena · DEHelixor Heilmittel (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapies of complementary and alternative medicine (CAM) are used increasingly in paediatric oncology. We present and discuss the influence of supportive mistletoe therapy on factors, such as quality of life, physical ability and performance, and course of disease based on the case of a female patient diagnosed at age 18 with metastasised neuroblastoma, which responded insufficiently to chemotherapy.

Indexed as

Activities of Daily LivingAdolescentAntineoplastic Agents, PhytogenicBone NeoplasmsBrain NeoplasmsEducational StatusFemaleHumansNeuroblastomaPhytotherapyPlant ExtractsQuality of LifeTreatment OutcomeAntineoplastic Agents, Phytogenichelixor APlant Extractscancer interventioncomplementary medicinepaediatric oncology

Identifiers

PMID30936335
PMCPMC6453412
OpenAlexW2931353011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.